These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 318216)

  • 1. Treatment of significant bacterial infections in adults with cefoxitin.
    Ribner BS; Billiard BS; Freimer EH
    Rev Infect Dis; 1979; 1(1):152-7. PubMed ID: 318216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoxitin therapy in aerobic, anaerobic, and mixed aerobic-anaerobic infections.
    LeFrock JL; Schell RF; Carr BB; Kowalsky SF; Tillotson JR
    Drug Intell Clin Pharm; 1982 Apr; 16(4):306-12. PubMed ID: 7067621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a clinical trial of cefoxitin, a new cephamycin antibiotic.
    McCloskey RV
    Antimicrob Agents Chemother; 1977 Nov; 12(5):636-41. PubMed ID: 335968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with cefoxitin in bacterial infections of children (author's transl)].
    Yuasa Y; Ichioka T; Sekiguchi T; Miyao M; Toi C; Hayashi K; Yamashita K; Tanaka H
    Jpn J Antibiot; 1981 Mar; 34(3):359-66. PubMed ID: 7289028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of cefoxitin, a new semisynthetic cephamycin.
    Little PJ; Peddie BA
    N Z Med J; 1978 Jul; 88(616):46-9. PubMed ID: 279853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefoxitin: clinical evaluation in thirty-eight patients.
    Heseltine PN; Busch DF; Meyer RD; Finegold SM
    Antimicrob Agents Chemother; 1977 Mar; 11(3):427-34. PubMed ID: 855997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and bacteriological evaluation of cefoxitin therapy in children.
    Jacobson JA; Santos JI; Palmer WM
    Antimicrob Agents Chemother; 1979 Aug; 16(2):183-5. PubMed ID: 485129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of skin, soft tissue, and bone infections with cefoxitin sodium.
    Perkins RL; Slama TG; Fass RJ; Prior RB; Plouffe JF; Warner JF; File TM
    Rev Infect Dis; 1979; 1(1):165-9. PubMed ID: 318218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections due to endemic, multiply resistant gram-negative rods: sensitivity to and therapy with cefoxitin.
    Alford RH
    Rev Infect Dis; 1979; 1(1):175-82. PubMed ID: 400932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and experimental evaluation of cefoxitin therapy.
    Webb D; Thadepalli H; Bach V; Roy I
    Chemotherapy; 1979; 25(4):233-42. PubMed ID: 378578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of cefoxitin in treatment of infections in 47 orthopedic patients.
    Schurman DJ; Dillingham M
    Rev Infect Dis; 1979; 1(1):206-9. PubMed ID: 318224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefoxitin: an overview of clinical studies in the United States.
    Neu HC
    Rev Infect Dis; 1979; 1(1):233-9. PubMed ID: 400937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefoxitin therapy for surgical patients.
    Rambo WM; Del Bene VE; Delamar DK
    Rev Infect Dis; 1979; 1(1):195-8. PubMed ID: 318221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of cefoxitin in the treatment of respiratory tract and other acute bacterial infections.
    Weinstein MP; Eickhoff TC
    Rev Infect Dis; 1979; 1(1):158-64. PubMed ID: 318217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefoxitin for treatment of infections due to anaerobic bacteria.
    Kirby BD; Busch DF; Citron DM; Finegold SM
    Rev Infect Dis; 1979; 1(1):113-7. PubMed ID: 318212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of cefoxitin and cephalothin: an overview.
    Neu HC
    Rev Infect Dis; 1979; 1(1):144-51. PubMed ID: 400931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections.
    Sweet RL; Ledger WJ
    Obstet Gynecol; 1979 Aug; 54(2):193-8. PubMed ID: 460753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical findings of cefoxitin in the treatment of serious infections and the prevention of postoperative infections (author's transl)].
    Ito H; Uno E; Ikeda M; Shimoji T; Higashi S; Yamamoto S
    Jpn J Antibiot; 1981 Sep; 34(9):1307-12. PubMed ID: 7328753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of piperacillin and cefoxitin in patients with bacteriologically confirmed infections.
    McCloskey RV
    Antimicrob Agents Chemother; 1986 Sep; 30(3):354-8. PubMed ID: 3535661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.